期刊： ENDOCRINOLOGY DIABETES & METABOLISM, 2022; 5 (4)
Objective To delineate the prevalence and associated risk factors of low BMD, osteoporosis/bone fragility and fracture in transfusion-dependent thalas......
期刊： ENDOCRINOLOGY DIABETES & METABOLISM, 2022; 5 (6)
Introduction The aim of the present study was to evaluate the effect of 18-week monotherapy with imeglimin on glucose tolerance and on insulin secreti......
期刊： ENDOCRINOLOGY DIABETES & METABOLISM, 2022; 5 (1)
Aims To compare 12-month clinical effectiveness of insulin glargine 300 units/mL (Gla-300) versus first-generation basal insulin analogues (BIAs) (ins......
期刊： ENDOCRINOLOGY DIABETES & METABOLISM, 2022; 5 (2)
Background Finger prick blood glucose (BG) monitoring remains a mainstay of management in people with type 2 diabetes (T2DM) who take sulphonylurea (S......
期刊： ENDOCRINOLOGY DIABETES & METABOLISM, 2022; 5 (6)
Introduction Subtype classification method is essential when considering adrenalectomy as a possible treatment for primary aldosteronism. We aimed to ......
期刊： ENDOCRINOLOGY DIABETES & METABOLISM, 2022; 5 (1)
Introduction This study examined the prevalence of microvascular and macrovascular complications in people receiving dialysis with and without diabete......
期刊： ENDOCRINOLOGY DIABETES & METABOLISM, 2022; 5 (4)
Introduction Cardiovascular diseases are known as one of the important causes of death in patients with diabetes mellitus. Metformin is used as an ora......
期刊： ENDOCRINOLOGY DIABETES & METABOLISM, 2022; 5 (3)
Background Subclinical hypothyroidism (SCH) is the commonest thyroid abnormality in patients with Down syndrome (DS). The purpose of this study was to......
期刊： ENDOCRINOLOGY DIABETES & METABOLISM, 2022; 5 (6)
Introduction Factitious hypoglycaemia is defined as the surreptitious use of insulin or oral hypoglycaemic agents to deliberately induce self-harm. It......
期刊： ENDOCRINOLOGY DIABETES & METABOLISM, 2022; 5 (6)
Introduction Severe hypercalcaemia is a life-threatening condition that should be managed urgently. The aim of this study was to assess the efficacy o......
期刊： ENDOCRINOLOGY DIABETES & METABOLISM, 2022; 5 (6)
Objective The cardio-renal benefits of sodium glucose-like transporter 2 inhibitor (SGLT2i) therapies have been demonstrated in patients with and with......
期刊： ENDOCRINOLOGY DIABETES & METABOLISM, 2022; 5 (3)
Background Preterm neonates are at risk for metabolic syndrome later in life. Whether prematurity constitutes an independent risk factor for the devel......
期刊： ENDOCRINOLOGY DIABETES & METABOLISM, 2022; 5 (5)
Introduction Diabetic ketoacidosis (DKA) is a serious acute complication of diabetes mellitus that carries a significant risk of mortality with delaye......
期刊： ENDOCRINOLOGY DIABETES & METABOLISM, 2022; 5 (1)
Aims Type 2 diabetes mellitus (T2DM) is a strong risk factor for complications of coronavirus disease 2019 (COVID-19). The effect of T2DM medications ......
期刊： ENDOCRINOLOGY DIABETES & METABOLISM, 2022; 5 (1)
Introduction: Diabetic macular oedema (DME) is one of the major cause of decreased visual acuity in patients with diabetic retinopathy. Poor glycaemic......
